Compare Aksara Global Development Tbk. (GAMA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aksara Global Development Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Aksara Global Development Tbk. trades at Rp18 (market cap 180.2B), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Aksara Global Development Tbk. and Brigit Biofarmaka Teknologi Tbk. are close in size by market cap. Which is the better fit depends on your goals.
| GAMA | OBAT | |
|---|---|---|
Market Cap | 180.2B | 166.01B |
Volume | — | 324K |
Lot | — | 3.24K |
Turnover | — | 77.68M |
Average Price | — | 239.75 |
Value | — | 77.68M |
Indicative Equilibrium Price | — | 240 |
Indicative Equilibrium Volume | — | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aksara Global Development Tbk.
PT Gading Development Tbk (formerly PT Artha Asia Pratama) was established based on notarial deed No. 45 dated December 18, 2003 of P. Sutrisno A. Tampubolon, S.H., M.Kn., notary in Jakarta.
Read more on GAMA →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
